A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers

作者: C Wu , S Mikhail , L Wei , C Timmers , S Tahiri

DOI: 10.1038/BJC.2015.197

关键词:

摘要: A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal gastro-oesophageal cancers

参考文章(21)
Petros D. Grivas, Stephanie Daignault, Scott T. Tagawa, David M. Nanus, Walter M. Stadler, Robert Dreicer, Manish Kohli, Daniel P. Petrylak, David J. Vaughn, Kathryn A. Bylow, Steven G. Wong, Joseph L. Sottnik, Evan T. Keller, Mahmoud Al-Hawary, David C. Smith, Maha Hussain, Double-Blind, Randomized, Phase 2 Trial of Maintenance Sunitinib Versus Placebo After Response to Chemotherapy in Patients With Advanced Urothelial Carcinoma Cancer. ,vol. 120, pp. 692- 701 ,(2014) , 10.1002/CNCR.28477
Nalini S Bora, Sankaranarayanan Kaliappan, Purushottam Jha, Qin Xu, Jeong-Hyeon Sohn, Dhara B Dhaulakhandi, Henry J Kaplan, Puran S Bora, None, Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H. Journal of Immunology. ,vol. 177, pp. 1872- 1878 ,(2006) , 10.4049/JIMMUNOL.177.3.1872
Hua Zhang, Jian Wu, Lin Meng, Cheng-Chao Shou, Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells World Journal of Gastroenterology. ,vol. 8, pp. 994- 998 ,(2002) , 10.3748/WJG.V8.I6.994
Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516
Xiangyu Yang, Jiachao Liang, Johannes T. Heverhagen, Guang Jia, Petra Schmalbrock, Steffen Sammet, Regina Koch, Michael V. Knopp, Improving the pharmacokinetic parameter measurement in dynamic contrast‐enhanced MRI by use of the arterial input function: Theory and clinical application Magnetic Resonance in Medicine. ,vol. 59, pp. 1448- 1456 ,(2008) , 10.1002/MRM.21608
Orestis Lyros, Annett Mueller, Florian Heidel, Carl C. Schimanski, Ines Gockel, Peter R. Galle, Hauke Lang, Markus Moehler, Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathways. International Journal of Cancer. ,vol. 127, pp. 1197- 1208 ,(2009) , 10.1002/IJC.25137
Hui K Gan, Bostjan Seruga, Jennifer J Knox, Sunitinib in solid tumors. Expert Opinion on Investigational Drugs. ,vol. 18, pp. 821- 834 ,(2009) , 10.1517/13543780902980171
Jordan M. Schmitt, Scott R. Sommers, William Fisher, Rafat Ansari, Erwin Robin, Karuna Koneru, John McClean, Ziyue Liu, Yan Tong, Nasser Hanna, Sunitinib Plus Paclitaxel in Patients with Advanced Esophageal Cancer: A Phase II Study from the Hoosier Oncology Groupe Journal of Thoracic Oncology. ,vol. 7, pp. 760- 763 ,(2012) , 10.1097/JTO.0B013E31824ABC7C
Paul D. Selid, Michael C. Jundt, Aaron C. Fortney, James R. Beal, Intravitreal bevacizumab and aflibercept for the treatment of exudative age-related macular degeneration. Ophthalmic Surgery and Lasers. ,vol. 45, pp. 275- 281 ,(2014) , 10.3928/23258160-20140709-03
Qiuyang Zhang, Chunhua Yu, Sui Peng, Hao Xu, Ellen Wright, Xi Zhang, Xiaofang Huo, Edaire Cheng, Thai H. Pham, Kiyotaka Asanuma, Kimmo J. Hatanpaa, Davood Rezai, David H. Wang, Venetia Sarode, Shelby Melton, Robert M. Genta, Stuart J. Spechler, Rhonda F. Souza, Autocrine VEGF Signaling Promotes Proliferation of Neoplastic Barrett's Epithelial Cells Through a PLC-Dependent Pathway Gastroenterology. ,vol. 146, pp. 461- 472 ,(2014) , 10.1053/J.GASTRO.2013.10.011